THRB and fatty liver disease: Furthermore, a synergistic effect was observed when BAM15 was combined with the THR-β agonist resmetirom, which significantly reduced hepatic steatosis and improved metabolism in a mouse model of fatty liver disease (Zhou et al., 2024).